The multidisciplinary practice at BonelliErede assists its clients in the healthcare and life sciences sectors in all manner of matters. The firm has deep knowledge of the pharmaceutical and biomedical markets, advising on matters involving EU and competition law, litigation, administrative issues, M&A, IP and tax. Other notable members within the practice include managing partner Andrea Carta Mantiglia, who specialises in M&A, litigation and international arbitration within the sector, and IP specialist Giovanni Guglielmetti. Sarah Lembo‘s broad expertise includes a focus on EU and anti-trust law. Vincenzo Salvatore left the practice in March 2024.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'High experience, broad capabilities and different expertises inside the BE team that can support in complex projects/discussions. Flexible and smart in finding the right solution for the customer (adapting to customer needs). Reactive and fast when there is urgency.'
Key clients
- Amylyx Pharmaceuticals
- Bausch & Lomb
- Biogen
- Bracco Imaging
- Chiesi Farmaceutici
- CSL Behring
- Dompé
- Gilead
- Immunogen
- Luxottica
- Kedrion
- Novartis
- Novocure
- Pfizer
- Pharming Group
- Pikdare
- Recordati
- Roche
Work highlights
- Assisting Biogen in challenging the approval of a generic medicine, the sale of which could constitute an anti-competitive measure for Biogen.
- Assisted Amylyx Pharmaceuticals during the assessment procedure before the EMEA CHMP for the launch of an innovative drug for AML.
- Providing Pharming Group with ongoing legal support on regulatory aspects and the drafting of commercial contracts (e.g. sponsorship agreements).